Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8794164rdf:typepubmed:Citationlld:pubmed
pubmed-article:8794164lifeskim:mentionsumls-concept:C0014279lld:lifeskim
pubmed-article:8794164lifeskim:mentionsumls-concept:C0966504lld:lifeskim
pubmed-article:8794164pubmed:issue4lld:pubmed
pubmed-article:8794164pubmed:dateCreated1996-10-18lld:pubmed
pubmed-article:8794164pubmed:abstractTextOf all the catalytic RNAs the hammerhead ribozyme is the most chemically modified and structurally studied. Such studies have resulted in improvements in the nuclease resistance of ribozymes, reductions in their size, and improvements in their catalytic efficiency. These improvements have facilitated the use of ribozymes for therapeutic applications, and have allowed us to study how the three-dimensional structure of the enzyme and its array of functional groups interact to create a catalytic site where a phosphodiester bond is cleaved.lld:pubmed
pubmed-article:8794164pubmed:languageenglld:pubmed
pubmed-article:8794164pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8794164pubmed:citationSubsetIMlld:pubmed
pubmed-article:8794164pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8794164pubmed:statusMEDLINElld:pubmed
pubmed-article:8794164pubmed:monthAuglld:pubmed
pubmed-article:8794164pubmed:issn0959-440Xlld:pubmed
pubmed-article:8794164pubmed:authorpubmed-author:UsmanNNlld:pubmed
pubmed-article:8794164pubmed:authorpubmed-author:McSwiggenJ...lld:pubmed
pubmed-article:8794164pubmed:authorpubmed-author:BeigelmanLLlld:pubmed
pubmed-article:8794164pubmed:issnTypePrintlld:pubmed
pubmed-article:8794164pubmed:volume6lld:pubmed
pubmed-article:8794164pubmed:ownerNLMlld:pubmed
pubmed-article:8794164pubmed:authorsCompleteYlld:pubmed
pubmed-article:8794164pubmed:pagination527-33lld:pubmed
pubmed-article:8794164pubmed:dateRevised2005-11-16lld:pubmed
pubmed-article:8794164pubmed:meshHeadingpubmed-meshheading:8794164-...lld:pubmed
pubmed-article:8794164pubmed:meshHeadingpubmed-meshheading:8794164-...lld:pubmed
pubmed-article:8794164pubmed:meshHeadingpubmed-meshheading:8794164-...lld:pubmed
pubmed-article:8794164pubmed:meshHeadingpubmed-meshheading:8794164-...lld:pubmed
pubmed-article:8794164pubmed:meshHeadingpubmed-meshheading:8794164-...lld:pubmed
pubmed-article:8794164pubmed:year1996lld:pubmed
pubmed-article:8794164pubmed:articleTitleHammerhead ribozyme engineering.lld:pubmed
pubmed-article:8794164pubmed:affiliationRibozyme Pharmaceuticals Inc, 2950 Wilderness Place, Boulder, CO 80301, USA.lld:pubmed
pubmed-article:8794164pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8794164pubmed:publicationTypeReviewlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8794164lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8794164lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8794164lld:pubmed